---
title: "Discover Global Penny Stocks: Zhongzhu Healthcare HoldingLtd Leads Our Trio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282172269.md"
description: "Zhongzhu Healthcare Holding Ltd, a penny stock with a market cap of CN¥5.48 billion, focuses on drug development in China. Despite being unprofitable, it has a sufficient cash runway and recently attracted investor interest with a 10.38% stake acquisition. The company generated CN¥570.62 million in revenue but has a negative return on equity of -32.97%. The article also highlights other penny stocks, including Nanfang Pump Industry and Wutong Holding Group, showcasing their financial health and growth potential amidst market volatility."
datetime: "2026-04-09T10:02:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282172269.md)
  - [en](https://longbridge.com/en/news/282172269.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282172269.md)
---

# Discover Global Penny Stocks: Zhongzhu Healthcare HoldingLtd Leads Our Trio

Global markets have been navigating a complex landscape, with recent geopolitical tensions and energy market volatility influencing investor sentiment. Against this backdrop, penny stocks emerge as intriguing opportunities for investors seeking growth potential at lower price points. Although the term "penny stocks" may seem outdated, these smaller or newer companies can offer substantial value when supported by strong financials and clear growth prospects.

### Top 10 Penny Stocks Globally

**Name**

**Share Price**

**Market Cap**

**Rewards & Risks**

North East Rubber (SET:NER)

THB4.88

THB9.02B

✅ 5 ⚠️ 2 View Analysis \>

Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)

THB3.40

THB1.42B

✅ 3 ⚠️ 3 View Analysis \>

Foresight Group Holdings (LSE:FSG)

£3.745

£425.41M

✅ 5 ⚠️ 0 View Analysis \>

Angler Gaming (NGM:ANGL)

SEK3.60

SEK269.95M

✅ 4 ⚠️ 2 View Analysis \>

Angler Gaming (DB:0QM)

€0.31

€239.95M

✅ 4 ⚠️ 3 View Analysis \>

PC Partner Group (SGX:PCT)

SGD1.58

SGD612.86M

✅ 4 ⚠️ 2 View Analysis \>

CNMC Goldmine Holdings (Catalist:5TP)

SGD1.53

SGD620.09M

✅ 4 ⚠️ 2 View Analysis \>

Focus Point Holdings Berhad (KLSE:FOCUSP)

MYR0.485

MYR298.25M

✅ 5 ⚠️ 2 View Analysis \>

Yangzijiang Shipbuilding (Holdings) (SGX:BS6)

SGD3.99

SGD15.7B

✅ 4 ⚠️ 2 View Analysis \>

Integrated Diagnostics Holdings (LSE:IDHC)

$0.61

$354.61M

✅ 4 ⚠️ 1 View Analysis \>

Click here to see the full list of 3,469 stocks from our Global Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

## Zhongzhu Healthcare HoldingLtd (SHSE:600568)

**Simply Wall St Financial Health Rating:** ★★★★★★

**Overview:** Zhongzhu Healthcare Holding Co., Ltd focuses on the research, development, production, and sale of drugs in China with a market capitalization of CN¥5.48 billion.

**Operations:** The company generates CN¥570.62 million in revenue from its operations within China.

**Market Cap:** CN¥5.48B

Zhongzhu Healthcare Holding Co., Ltd, with a market cap of CN¥5.48 billion and revenue of CN¥570.62 million, is debt-free and has a sufficient cash runway exceeding three years despite being unprofitable. The company's management and board are relatively new, with an average tenure of 1.3 years, indicating potential for strategic shifts. Recent developments include the acquisition of a 10.38% stake by Gongqingcheng Meihua Tenglong Qifei Investment Partnership Enterprise for approximately CN¥400 million, signaling investor interest despite ongoing profitability challenges and negative return on equity at -32.97%.

-   Navigate through the intricacies of Zhongzhu Healthcare HoldingLtd with our comprehensive balance sheet health report here.
-   Examine Zhongzhu Healthcare HoldingLtd's past performance report to understand how it has performed in prior years.

SHSE:600568 Financial Position Analysis as at Apr 2026

## Nanfang Pump Industry (SZSE:300145)

**Simply Wall St Financial Health Rating:** ★★★★★☆

**Overview:** Nanfang Pump Industry Co., Ltd. is involved in the research, design, development, production, and sale of pump products both in China and internationally, with a market cap of CN¥8.63 billion.

**Operations:** No specific revenue segments are reported for Nanfang Pump Industry Co., Ltd.

**Market Cap:** CN¥8.63B

Nanfang Pump Industry Co., Ltd., with a market cap of CN¥8.63 billion, has demonstrated consistent earnings growth over the past five years, averaging 67.1% annually, although recent growth slowed to 5.9%. Despite a large one-off loss of CN¥108.3 million affecting its latest financial results, the company remains financially stable with short-term assets of CN¥5.5 billion exceeding both short and long-term liabilities. Its net debt to equity ratio is satisfactory at 37.4%, and interest coverage is not an issue due to adequate earnings performance. The company's Price-to-Earnings ratio stands at 34.5x, below the Chinese market average.

-   Jump into the full analysis health report here for a deeper understanding of Nanfang Pump Industry.
-   Understand Nanfang Pump Industry's earnings outlook by examining our growth report.

SZSE:300145 Financial Position Analysis as at Apr 2026

## Wutong Holding Group (SZSE:300292)

**Simply Wall St Financial Health Rating:** ★★★★★★

**Overview:** Wutong Holding Group Co., Ltd. manufactures and sells intelligent telecommunication devices in China and has a market cap of CN¥6.49 billion.

**Operations:** The company has not reported any specific revenue segments.

**Market Cap:** CN¥6.49B

Wutong Holding Group, with a market cap of CN¥6.49 billion, has shown impressive earnings growth of 121.8% over the past year, outpacing the Communications industry. The company's debt to equity ratio has significantly improved from 44.2% to 16.8% in five years, and it holds more cash than total debt, indicating strong financial health. Its Price-to-Earnings ratio of 62.8x is below the industry average, suggesting potential value for investors despite its low Return on Equity at 8.1%. Short-term assets comfortably cover liabilities, and interest payments are well covered by EBIT (24x).

-   Take a closer look at Wutong Holding Group's potential here in our financial health report.
-   Review our historical performance report to gain insights into Wutong Holding Group's track record.

SZSE:300292 Financial Position Analysis as at Apr 2026

## Key Takeaways

-   Unlock more gems! Our Global Penny Stocks screener has unearthed 3,466 more companies for you to explore.Click here to unveil our expertly curated list of 3,469 Global Penny Stocks.
-   Curious About Other Options? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

_This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

### Valuation is complex, but we're here to simplify it.

Discover if Nanfang Pump Industry might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.**

Access Free Analysis

### Related Stocks

- [600568.CN](https://longbridge.com/en/quote/600568.CN.md)

## Related News & Research

- [Asian Penny Stocks To Follow In May 2026](https://longbridge.com/en/news/286683624.md)
- [European Market Insights: 3 Penny Stocks With Market Caps Below €200M](https://longbridge.com/en/news/286721387.md)
- [Lupin bets big on India's GLP-1 market & respiratory drugs](https://longbridge.com/en/news/287021542.md)
- [00:45 ETAraceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery](https://longbridge.com/en/news/287006505.md)
- [Kivo Launches Headless GxPTM to Power Compliant Agentic AI in Drug Development](https://longbridge.com/en/news/287071239.md)